Biogen Pharmachem Industries Limited (BOM:531752)
India · Delayed Price · Currency is INR 0.9200
-0.0100 (-1.08%)
At close: Aug 6, 2025
BOM:531752 Revenue
Biogen Pharmachem Industries had revenue of 15.43M INR in the quarter ending June 30, 2025, a decrease of -1,797.25%. This brings the company's revenue in the last twelve months to 16.34M, up 6.26% year-over-year.
Revenue (ttm)
16.34M
Revenue Growth
+6.26%
P/S Ratio
36.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
600.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | 7.89M | 5.39M | 215.26% |
| Mar 31, 2023 | 2.50M | -22.31M | -89.91% |
| Mar 31, 2022 | 24.81M | 8.58M | 52.90% |
| Mar 31, 2021 | 16.23M | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Hindustan Unilever | 639.28B |
| Infosys | 1,672.76B |